These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2178457)

  • 21. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results.
    Phibbs RH; Shannon KM; Mentzer WC
    Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin in neonatal anemia.
    Shannon K
    Clin Perinatol; 1995 Sep; 22(3):627-40. PubMed ID: 8521685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoiesis and the approach to anemia in premature infants.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):97-9. PubMed ID: 23025780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating erythroid progenitors in the anemia of prematurity.
    Shannon KM; Naylor GS; Torkildson JC; Clemons GK; Schaffner V; Goldman SL; Lewis K; Bryant P; Phibbs R
    N Engl J Med; 1987 Sep; 317(12):728-33. PubMed ID: 3627181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
    Strauss RG
    Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron status and the treatment of the anemia of prematurity.
    Kling PJ; Winzerling JJ
    Clin Perinatol; 2002 Jun; 29(2):283-94. PubMed ID: 12168242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red blood cell transfusion practices in the neonate.
    Strauss RG
    Clin Perinatol; 1995 Sep; 22(3):641-55. PubMed ID: 8521686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of recombinant human erythropoietin on transfusion needs in preterm infants.
    Yeo CL; Choo S; Ho LY
    J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
    Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human erythropoietin as a treatment for anemia of prematurity.
    Downey P
    J Perinat Neonatal Nurs; 1997 Dec; 11(3):57-68. PubMed ID: 9451192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin in very preterm infants.
    Fernandes CJ; Hagan R; Frieberg A; Grauaug A; Kohan R
    J Paediatr Child Health; 1994 Aug; 30(4):356-9. PubMed ID: 7946551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal anemia: pathophysiology and treatment.
    Strauss RG
    Immunol Invest; 1995; 24(1-2):341-51. PubMed ID: 7713595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors: Part II.
    Wandstrat TL; Wolfe M
    Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant erythropoietin for prevention of anemia in preterm infants.
    Obladen M; Maier RF
    J Perinat Med; 1995; 23(1-2):119-26. PubMed ID: 7658311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood product transfusion in the neonatal period].
    Arnaud F; Simeoni U
    Transfus Clin Biol; 2005 Oct; 12(4):336-41. PubMed ID: 16169272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
    Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.